The global probe reprocessing market is estimated to be USD 0.846 billion in 2024 and is expected to reach USD 2.55 billion by 2035, with a CAGR of 10.57% during the forecast period 2025-2035. The market will grow due to a number of factors, including the rising occurrence of hospital-acquired infections, the growing utilization of echocardiograms, strict regulatory requirements and compliance guidelines, technological advancements in reprocessing equipment, and strategic alliances and partnerships.
The growing utilization of echocardiograms in the U.S., as highlighted by MedStar Health in January 2024, with over 7 million procedures conducted annually, underscores the increasing demand for cardiac ultrasound solutions. This surge is driving the adoption of phased array and cardiac probes, which play a critical role in cardiac imaging. To maintain safety and operational efficiency, the heightened use of these probes necessitates robust probe reprocessing solutions. Effective cleaning, disinfection, and sterilization are essential to prevent contamination and ensure compliance with stringent healthcare regulations. This trend is expected to significantly boost the growth of the global probe reprocessing market.
By probe classification, the semi-critical sterilizers segment accounted for the highest revenue-grossing segment in the global probe reprocessing market in 2024 owing to the increasing use of semi-critical probes like endocavitary and TEE probes, which require stringent sterilization to prevent cross-contamination and meet regulatory guidelines. For instance, in September 2024, Germitec's Chronos received the U.S. FDA's first-ever De Novo classification for an ultraviolet radiation disinfection chamber equipment. Designed to disinfect external ultrasonography and endocavitary probes, this chemical-free UV-C high-level disinfection (HLD) device provides a quick, efficient, and eco-friendly substitute for conventional chemical-based disinfection techniques. With the FDA's approval, UV-C technology for medical device cleanliness has advanced to a major milestone. Additionally, the non-critical segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for effective reprocessing solutions for surface probes used in routine diagnostic procedures, driven by cost-effectiveness and reduced infection risks.
By probe type, the Transesophageal (TEE) probes segment accounted for the highest revenue-grossing segment in the global probe reprocessing market in 2024 owing to the wide usage of TEE probes in cardiac imaging and their critical role in minimally invasive procedures, necessitating frequent high-level disinfection and sterilization. For instance, the European Centre for Disease Prevention and Control (ECDC) reported in May 2024 that every year, some 4.3 million hospital patients in the EU/EEA are impacted by HAIs. Additionally, the phased array/cardiac probes segment is predicted to grow at the fastest CAGR during the forecast period owing to its increasing use in cardiac imaging for echocardiograms, coupled with advancements in probe technology and the rising prevalence of cardiovascular diseases.
By method, the high-level disinfection segment accounted for the highest revenue-grossing segment in the global probe reprocessing market in 2024 owing to the critical need for eliminating all microorganisms on semi-critical probes, supported by stringent healthcare regulations and guidelines for infection prevention. For instance, Tristel Plc declared in June 2023 that Tristel ULT, its cutting-edge high-level disinfection created especially for ultrasound probes, had received FDA approval. Additionally, the intermediate level disinfection segment is predicted to grow at the fastest CAGR during the forecast period owing to its growing adoption for non-critical probes used in routine imaging procedures, offering an effective yet cost-efficient method of reprocessing.
By end-user, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global probe reprocessing market in 2024 owing to the high patient volume and the need for maintaining strict hygiene standards in diverse diagnostic and surgical applications. For instance, the Association for Professionals in Infection Control and Epidemiology (APIC) and CS Medical announced a strategic partnership for 2023 in February 2023. Through utilizing APIC's leadership in infection control and CS Medical's proficiency in medical equipment cleaning, this partnership seeks to improve infection prevention procedures. Additionally, the diagnostic imaging centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for specialized imaging services and the increasing adoption of advanced probes that require effective reprocessing solutions.
North American region is anticipated to have the highest revenue share during the forecast period owing to the presence of advanced healthcare infrastructure, strict regulatory standards for infection control, high adoption of advanced medical devices, and significant investments in probe reprocessing technologies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing awareness about infection control, rising medical tourism, and the growing demand for diagnostic and therapeutic procedures in emerging economies such as India and China. For instance, in June 2023, Avanos Medical, Inc. declared that it had reached a final deal to purchase Diros Technology Inc., a prominent producer of cutting-edge radiofrequency (RF) devices for the treatment of chronic pain.
This comprehensive research report focuses on the global and regional market size and forecasts from 2024 to 2035.
The growing utilization of echocardiograms in the U.S., as highlighted by MedStar Health in January 2024, with over 7 million procedures conducted annually, underscores the increasing demand for cardiac ultrasound solutions. This surge is driving the adoption of phased array and cardiac probes, which play a critical role in cardiac imaging. To maintain safety and operational efficiency, the heightened use of these probes necessitates robust probe reprocessing solutions. Effective cleaning, disinfection, and sterilization are essential to prevent contamination and ensure compliance with stringent healthcare regulations. This trend is expected to significantly boost the growth of the global probe reprocessing market.
By probe classification, the semi-critical sterilizers segment accounted for the highest revenue-grossing segment in the global probe reprocessing market in 2024 owing to the increasing use of semi-critical probes like endocavitary and TEE probes, which require stringent sterilization to prevent cross-contamination and meet regulatory guidelines. For instance, in September 2024, Germitec's Chronos received the U.S. FDA's first-ever De Novo classification for an ultraviolet radiation disinfection chamber equipment. Designed to disinfect external ultrasonography and endocavitary probes, this chemical-free UV-C high-level disinfection (HLD) device provides a quick, efficient, and eco-friendly substitute for conventional chemical-based disinfection techniques. With the FDA's approval, UV-C technology for medical device cleanliness has advanced to a major milestone. Additionally, the non-critical segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for effective reprocessing solutions for surface probes used in routine diagnostic procedures, driven by cost-effectiveness and reduced infection risks.
By probe type, the Transesophageal (TEE) probes segment accounted for the highest revenue-grossing segment in the global probe reprocessing market in 2024 owing to the wide usage of TEE probes in cardiac imaging and their critical role in minimally invasive procedures, necessitating frequent high-level disinfection and sterilization. For instance, the European Centre for Disease Prevention and Control (ECDC) reported in May 2024 that every year, some 4.3 million hospital patients in the EU/EEA are impacted by HAIs. Additionally, the phased array/cardiac probes segment is predicted to grow at the fastest CAGR during the forecast period owing to its increasing use in cardiac imaging for echocardiograms, coupled with advancements in probe technology and the rising prevalence of cardiovascular diseases.
By method, the high-level disinfection segment accounted for the highest revenue-grossing segment in the global probe reprocessing market in 2024 owing to the critical need for eliminating all microorganisms on semi-critical probes, supported by stringent healthcare regulations and guidelines for infection prevention. For instance, Tristel Plc declared in June 2023 that Tristel ULT, its cutting-edge high-level disinfection created especially for ultrasound probes, had received FDA approval. Additionally, the intermediate level disinfection segment is predicted to grow at the fastest CAGR during the forecast period owing to its growing adoption for non-critical probes used in routine imaging procedures, offering an effective yet cost-efficient method of reprocessing.
By end-user, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global probe reprocessing market in 2024 owing to the high patient volume and the need for maintaining strict hygiene standards in diverse diagnostic and surgical applications. For instance, the Association for Professionals in Infection Control and Epidemiology (APIC) and CS Medical announced a strategic partnership for 2023 in February 2023. Through utilizing APIC's leadership in infection control and CS Medical's proficiency in medical equipment cleaning, this partnership seeks to improve infection prevention procedures. Additionally, the diagnostic imaging centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for specialized imaging services and the increasing adoption of advanced probes that require effective reprocessing solutions.
North American region is anticipated to have the highest revenue share during the forecast period owing to the presence of advanced healthcare infrastructure, strict regulatory standards for infection control, high adoption of advanced medical devices, and significant investments in probe reprocessing technologies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing awareness about infection control, rising medical tourism, and the growing demand for diagnostic and therapeutic procedures in emerging economies such as India and China. For instance, in June 2023, Avanos Medical, Inc. declared that it had reached a final deal to purchase Diros Technology Inc., a prominent producer of cutting-edge radiofrequency (RF) devices for the treatment of chronic pain.
This comprehensive research report focuses on the global and regional market size and forecasts from 2024 to 2035.
Report Scope:
- Base Year: 2024
- Forecast Period: 2025-2035
- Study Coverage
- Market Forecast by Probe Classification, Probe Type, method, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Probe Reprocessing Market Report 2024 - 2035
Probe Reprocessing Market Analysis & Forecast by Probe Classification 2024 - 2035 (Revenue USD Bn)
- Semi-Critical
- Non-Critical
- Critical
Probe Reprocessing Market Analysis & Forecast by Probe Type 2024 - 2035 (Revenue USD Bn)
- Convex Probes
- Linear Probes
- Transesophageal (TEE) Probes
- Phased Array/Cardiac Probes
- Endocavitary Probes
- Others
Probe Reprocessing Market Analysis & Forecast by Method 2024 - 2035 (Revenue USD Bn)
- Sterilization
- High-Level Disinfection
- Intermediate Level Disinfection
- Low-Level Disinfection
Probe Reprocessing Market Analysis & Forecast by End-User 2024 - 2035 (Revenue USD Bn)
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Others
Probe Reprocessing Market Analysis & Forecast by Region 2024 - 2035 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Probe Reprocessing Market: Probe Classification Estimates & Trend Analysis
8. Probe Reprocessing Market: Probe Type Estimates & Trend Analysis
9. Probe Reprocessing Market: Method Estimates & Trend Analysis
10. Probe Reprocessing Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Probe Reprocessing Market
13. Europe Global Probe Reprocessing Market
14. Asia Pacific Global Probe Reprocessing Market
15. Latin America Global Probe Reprocessing Market
16. MEA Global Probe Reprocessing Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Nanosonics Ltd.
- Steris PLC
- Ecolab, Inc.
- CS Medical LLC
- GE Healthcare
- Advanced Sterilization Products (ASP)
- Tristel Solutions Ltd.
- Metrex Research, LLC
- Soluscope SAS
- Medivators, Inc. (Cantel Medical)
- CIVCO Medical Solutions
- Johnson & Johnson
- Schülke & Mayr GmbH
- Siemens Healthineers
- Philips Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | December 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 0.85 Billion |
| Forecasted Market Value ( USD | $ 2.55 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
